← Open Payments lookup

AURORA MELLIJOR-SOLIGUEN: Open Payments

NPI 1417978537 · UPLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,042 in 42 payments from 10 companies in 2025. Trend: 2023 $764 · 2024 $660 · 2025 $1,042

Food & beverage: $1,042
CompanyPaymentsAmount
Alkermes, Inc.7$291
ABBVIE INC.8$179
Axsome Therapeutics, Inc.8$147
Otsuka America Pharmaceutical, Inc.5$140
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$110
Almatica Pharma LLC3$57
Takeda Pharmaceuticals U.S.A., Inc.3$45
E.R. Squibb & Sons, L.L.C.1$29
Janssen Pharmaceuticals, Inc1$26
TMS NeuroHealth Centers Inc.1$19

Products named: VRAYLAR, ARISTADA, Auvelity, REXULTI, LYBALVI, CAPLYTA, LOREEV XR, TRINTELLIX.

Industry payments across CA — which companies pay providers there.